Tender Details

Country: Belgium
Summary: Development of a Rapid Point-Of-Care Antimicrobial Susceptibility Testing Diagnostic Medical Device
BET Ref No: 116664043
Deadline: 12 May 2025
Financier: Other Funding Agencies
Purchaser Ownership: Government
Tender Value: EUR 12860000
Notice Type: Tender
Document Ref. No.: 186319-2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
This call for tenders aims to speed up the development of a point-of-care diagnostic medical device that can provide antimicrobial susceptibility results on the bacteria or fungi causing an infection in humans, within one hour or less from subject sample collection, and ideally, to also allow for pathogen identification. Diagnostic tests that allow for pathogen identification (in addition to AST) should aim at identifying at least one of the bacteria listed in the 2024 WHO bacterial pathogen priority list and/or the fungi Candida spp., and/or Aspergillus fumigatus. The call aims to speed up the development of rapid, point-of-care AST devices currently in the pipeline. The proposed product shall be at minimum technology readiness level (TRL) 3 onwards with a clear pathway for CE marking in the EU. By the end of the contract, the product developed should aim at reaching system complete and qualified (TRL 8). Tenders aiming at early TRLs will be considered, as long as the product is working towards certification.
Doc Title: Development of a rapid point-of-care antimicrobial susceptibility testing diagnostic medical device
Contract Type: services
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Development of a Rapid Point-Of-Care Antimicrobial Susceptibility Testing Diagnostic Medical Device - Belgium Tender

The HEALTH AND DIGITAL EXECUTIVE AGENCY (HADEA) , HADEA - HEALTH AND DIGITAL EXECUTIVE AGENCY, a Government sector organization in Belgium, has announced a new tender for Development of a Rapid Point-Of-Care Antimicrobial Susceptibility Testing Diagnostic Medical Device. This tender is published on BelgiumTenders under BET Ref No: 116664043 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-12.

The estimated tender value is EUR 12860000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.